Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(14%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_3
1
7%
Ph phase_1
1
7%
Ph phase_2
1
7%
Ph not_applicable
1
7%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(7)

Detailed Status

unknown7
Completed4
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting214%
unknown750%
completed429%
terminated17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
14